These techniques help seal the wound and prevent further bleeding
however, it is not licensed for weight loss, but rather for the treatment of type 2 diabetes
But according to a representative for both brands, TFC8 is designed to renew skin and combat existing signs of aging, and TFC5 is a proactive option for younger skin (its described on the DUA site as being tailored for skin with minimal to moderate damage)
Compound Overview & Target Pathways Retatrutide is commonly referenced as a triple peptidic agonist in scientific literature involving GLP-1, GIP, and glucagon receptor pathway models
Strumila R, Nobile B, Korsakova L, Lengvenyte A, Olie E, Lopez-Castroman J, et al